CONVATEC GROUP PLC RNS Number : 7474O ConvaTec Group PLC 21 May 2018
21 May 2018
ConvaTec Group Plc
("ConvaTec" or "the Company")
Director/PDMR Shareholding
The Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").
On 17 May 2018 Mr Paul Moraviec, the Chief Executive Officer and a PDMR, acquired 32,791 Shares at £2.27 per share under the terms of the dividend reinvestment plan operated by the Company's registrars for employees holding shares within its Share Plan Account. Mr Moraviec's resulting shareholding is 5,005,300 Shares.
The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1 | Details of the person discharging managerial responsibilities/person closely associated | |||
a) | Name | Mr Paul Moraviec | ||
2 | Reason for the notification | |||
a) | Position/Status | Chief Executive Officer | ||
b) | Initial notification/Amendment | Initial Notification | ||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||
a) | Name | ConvaTec Group Plc | ||
b) | LEI | 213800LS272L4FIDOH92 | ||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 10p each in ConvaTec Group Plc ("Shares") GB00BD3VFW73 | ||
b) | Nature of the transaction | Acquisition of Shares under the terms of the dividend reinvestment plan operated by the Company's registrars for employees holding shares within its Share Plan Account | ||
c) | Price(s) and volume(s) | Price(s) £2.2707 | Volume(s) 32,791 | |
d) | Aggregated information - Aggregated volume - Price | 32,791 £74,458.52 | ||
e) | Date of the transaction | 17 May 2018 | ||
f) | Place of the transaction | London Stock Exchange, Main Market (XLON) | ||
Enquiries
Media
Bobby Leach, VP Group Corporate Affairs, ConvaTec | +44 (0)7770 842 226 |
Alastair Elwen, Finsbury | +44 (0)207 251 3801 |
Analysts and Investors | |
John Crosse, VP Investor Relations, ConvaTec | +44 (0)7500 141 435 |
Kirsty Law, Director Investor Relations, ConvaTec | +44 (0)7470 909 582 |
investorrelations@convatec.com |
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visitwww.convatecgroup.com where a copy of this announcement can also be found.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contactrns@lseg.com or visitwww.rns.com.
END
DSHLLFELEAILFIT
Attachments
- Original document
- Permalink
Disclaimer
ConvaTec Group plc published this content on 21 May 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 21 May 2018 12:14:02 UTC
